'It is admitted that the AZ vaccine can, in very rare cases, cause TTS.' IMAGE: A vial labelled 'AstraZeneca COVID-19 Vaccine'. Photograph: Illustration/Dado Ruvic/Reuters The controversial......
India has been offered 7.5 million doses of Moderna's COVID-19 vaccine through the COVAX global vaccine sharing programme, but it is not clear when the jabs will arrive in the country as a......
However, before the Moderna and Pfizer messenger ribonucleic acid (or mRNA) vaccines come to India via this route, the legalities around the indemnity clause will have to be settled, reports Sohini......
Prime Minister Narendra Modi on Thursday called for reforming the World Health Organisation and streamlining its approval process for vaccines and therapeutics, and favoured making flexible the......
Calling for 'equal recognition of vaccines', COVAX on Thursday urged all governments to recognise as 'fully vaccinated' those people who have received COVID-19 vaccines deemed safe by World Health......
India's economy, which contracted by 7.3 per cent due to the COVID-19 pandemic, is expected to grow by 9.5 per cent in 2021 and 8.5 per cent in 2022, according to latest projections released by the......
The focus of the company would be to develop its capability across segments of injectables, vaccines, biosimilars, inhalation and APIs to drive growth. Aurobindo Pharma’s December-quarter......
Serum Institute of India plans to make 300 million doses of AZD1222 by December, and will begin phase-2 trials soon. It has also tied up with Novavax for development and commercialisation of its......
The procurement and distribution will be centralised though the government is yet to take a call on the initial number of doses that will be procured. India plans to create a digital......